WallStreetZenWallStreetZen

NASDAQ: CNTB
Connect Biopharma Holdings Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CNTB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$59.5M
Current Profit Margin
0%

CNTB Return on Equity

Current Company
-46%
Current Industry
-63.5%
Current Market
188%
CNTB's Return on Equity (-47.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CNTB announces earnings.

CNTB Return on Assets

Current Company
-39.7%
Current Industry
2.9%
CNTB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CNTB Return on Capital Employed

Current Company
-58.41%
Current Industry
19.5%
CNTB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNTB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CNTB$0.00-$59.36M-$59.50MN/AN/A
GRTS$16.34M-$112.80M-$138.49M+68.96%N/A
CGTX$0.00-$25.51M-$25.79MN/AN/A
AFMD$8.99M-$114.03M-$115.15M-19.55%N/A
YSN/AN/AN/AN/AN/A
View Top Biotech Stocks

Connect Biopharma Holdings Earnings & Revenue FAQ

What were CNTB's earnings last quarter?

Connect Biopharma Holdings (NASDAQ: CNTB) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Connect Biopharma Holdings earnings for the quarter were N/A. In the same quarter last year, Connect Biopharma Holdings's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.

What was CNTB's earnings growth in the past year?

As of Q2 2024, Connect Biopharma Holdings's earnings has grown year over year. Connect Biopharma Holdings's earnings in the past year totalled -$59.50 million.

What was CNTB's revenue last quarter?

Connect Biopharma Holdings (NASDAQ: CNTB) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Connect Biopharma Holdings's revenue was N/A.

What was CNTB's revenue growth in the past year?

As of Q2 2024, Connect Biopharma Holdings's revenue has grown null year over year. Connect Biopharma Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.